Unknown OBSERVATIONAL NCT05289895

Prognostic Biomarkers of Pancreatic Cancer Based on Proteomic Techniques

Clinical Study on Prognostic Biomarkers of Pancreatic Cancer Based on Proteomic Technique

Sponsor: The Affiliated Hospital of Qingdao University

Conditions Pancreatic Cancer Prognostic Biomarkers Proteomics

Updated 4 times since 2022 Last updated: Mar 17, 2022 Started: Apr 1, 2022 Primary completion: Mar 1, 2023 Completion: Dec 30, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Pancreatic Cancer and Prognostic Biomarkers, this trial is ongoing. The trial is conducted by The Affiliated Hospital of Qingdao University and has accumulated 4 data snapshots since 2022. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

4 versions recorded

Feb 2025 — Present [monthly]

Unknown

Status: Not Yet Recruiting → Unknown
Sep 2024 — Feb 2025 [monthly]

Not Yet Recruiting
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting
Apr 2022 — Jul 2024 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Affiliated Hospital of Qingdao University

Data source: The Affiliated Hospital of Qingdao University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.